SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
261 hedge funds and large institutions have $3.97B invested in Sage Therapeutics in 2021 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 79 increasing their positions, 87 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
15% less capital invested
Capital invested by funds: $4.65B → $3.97B (-$680M)
49% less call options, than puts
Call options by funds: $48.7M | Put options by funds: $96.2M
Holders
261
Holding in Top 10
6
Calls
$48.7M
Puts
$96.2M
Top Buyers
| 1 | +$71.2M | |
| 2 | +$66M | |
| 3 | +$60.7M | |
| 4 |
BlackRock
New York
|
+$30M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25M |
Top Sellers
| 1 | -$52.8M | |
| 2 | -$38.2M | |
| 3 | -$38.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$35.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$30.6M |